Patients presenting with out of hospital cardiac arrest (OHCA) and no evidence of extra-cardiac cause have a poor short term outcome. This study sought to identify which post-cardiac arrest patients may or may not benefit from emergency coronary angiography (ECA) and primary percutaneous coronary intervention (PCI).
Methods:
In this non interventionnal monocentric study, pts admitted in the ED of Grenoble University Hospital for syncope were prospectively included from July 2013 to January 2014. The SYNCSCOR was calculated a posteriori for all pts. The main objective was to validate the tool for the prediction of serious outcomes within 3 months (death, major cardiovascular events, cardiovascular interventional therapy, return to hospital for a related event).
Results: 94 pts were included (males 54%, mean age 66 years old, history of cardiopathy 56%). 97% had biological testing in the ED and 77% imaging evaluation. After the ED evaluation, 39% were admitted (hospitalization>12H), 45% were addressed to outpatient clinic and 16% were released. In 64% of cases, a diagnostic was done in the ED. Serious outcomes occurred in 25 pts. The sensitivity and specificity, of SYNCSCOR for the primary criteria was 96% (95% Confidence interval [CI] 80 to 99%) and 24% (95% CI 16 to 36%) whereas 88% (95% CI 70 to 96%) and 18% (95% CI 7% to 24%) for the ED clinician alone. The negative predictive value of the tool was 94% (95% CI 73 to 99%). According to SYN-SCOR, 50% of pts should benefit from an intensive evaluation and 20% can have a direct release.
Conclusion:
SYNCSCOR is a useful screening tool to improve reliability to the recommendations in the ED. It can help to limit no necessary complementary exams, overprescribed for patients at low risk, and to lead patients to an immediate intensive evaluation (syncope unit) in case of high risk criteria. As SYNCSCOR is only based on clinical parameters, this tool can be easily proposed in the community care. Background: Cardiogenic shock, mainly due to an acute coronary syndrome (ACS), is still subject to a high mortality despite early coronary revascularization. Nowadays, transient percutaneous left ventricular assist device, like Impella 2.5 (Abiomed®), would improve the hemodynamic situation and the survival.
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Methods: In our institution, all the patients treated with Impella 2.5 as first line therapy for a cardiogenic shock consecutive to ACS were retrospectively included. The mortality at day 30, the hemodynamic efficacy and complications have been analyzed. ) were included (12 cardiac arrest, 59% STEMI).The Impella 2.5 device provided effective hemodynamic support (CI increased by 16%, lung and capillary pressures respectively reduced by 36% and 28%). Survival at day 30 was 59%, and it has been maintained up to 6 months. Factors associated with mortality were incomplete revascularization (p<0.01), age >70 years (p=0.07), a SOFA score ≥9 (p =0.02) and blood lactate >6.3 mmol/L (p=0.07) at implantation.
Results

Conclusion:
This couraging results in our single-center experience should be confirmed by a randomized controlled trial.
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Public access defibrillators location strategy in major urban aeras using geographic optimization, is there an optimal number? Benjamin Dahan (1), Patricia Jabre (1), Renaud Misslin (2), Muriel Tafflet (1) Purpose: In major cities, optimal distribution of automatic external defibrillators (AED) has long been debated. International guidelines recommended placing AED where at least an out-of-hospital cardiac arrest (OHCA) occurs every 2 years. However, bystander awareness of AED location is often limited. The aim of the study was to determine a potential strategic AED placement policy.
Methods:
We included all OHCA managed in Paris by Emergency Medical Services between 2000 and 2010. First, we worked on different scenarios of regular AED placement according to several deployment distances (from 200 meters to 2000 meters), then we analyzed median distance between these AED potential placements and included OHCA. Second, we identified different types of public facilities in Paris and we calculated the median distance according to each type of public facilities. We evaluated the number needed of AED in each case.
Results: Among the 4176 OHCA of presumed cardiac etiology, 1415 (34%) occurred out-of-home and 1355 were eventually geocoded (Figure) . Median distances between OHCA and district councils (n=20), post offices (n=195), subway stations (n=302), bike sharing stations (n=957) and pharmacies (n=1466) were 1052, 324, 239, 137 and 142 meters respectively.
Conclusion:
Increasing number of AED following a regular distribution on the territory decreases drastically the median distance between AED potential placement and OHCA until a certain number (350 AED for Paris). Additional AED placement benefit becomes less apparent. AED public facilities coverage strategy may help to optimize AED placement. The choice of the best public facility should be based on its number and repartition on the territory and its proximity to OHCA. 
